Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06952556 · ClinicalTrials.gov registry record · Phase 4
Adductor Canal Block and IPACK Block vs. Isolated Adductor Canal Block for Post-Operative Analgesia Following HTO/DFO/TTO
A Phase 4 study of Analgesia, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06952556 is a Phase 4 study of Analgesia that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 100 participants, above the 88-participant average among 19 other Analgesia trials with a reported enrollment target (14% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06952556, a Phase 4 study of Analgesia, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
A randomized, single-blind, single-center study measuring the effects of adductor canal block combined with IPACK infiltration compared to adductor canal block alone on post-operative pain and opioid consumption in patients undergoing high tibial osteotomy (HTO)/distal femoral osteotomy (DFO)/tibial tubercle osteotomy (TTO).
Conditions Studied
Interventions
- DRUG ACB
- DRUG IPACK block
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-04-28 |
| Est. Completion | 2027-06-28 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06952556
The ClinicalTrials.gov registry entry for NCT06952556 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 88-participant average among 19 other Analgesia trials with a reported enrollment target (14% higher). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Analgesia appearing as the primary indexed condition, and to 2 interventions - of which ACB is the first listed.
NCT06952556 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06952556 about?
NCT06952556 is a clinical study titled "Adductor Canal Block and IPACK Block vs. Isolated Adductor Canal Block for Post-Operative Analgesia Following HTO/DFO/TTO". A randomized, single-blind, single-center study measuring the effects of adductor canal block combined with IPACK infiltration compared to adductor canal block alone on post-operative pain and opioid consumption in patients undergoing high tibial osteotomy (HTO)/distal femoral osteotomy (DFO)/tibial...
What is the current status of trial NCT06952556?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2025-04-28. Estimated completion is 2027-06-28.
What conditions does trial NCT06952556 study?
This clinical trial studies the following conditions: Analgesia.
What interventions are being tested in trial NCT06952556?
The interventions under investigation include: ACB (DRUG), IPACK block (DRUG).
Who is sponsoring clinical trial NCT06952556?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06952556 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Analgesia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Transversus Abdominis Plane Block Compared to Local Anesthetic Wound Infiltration in Gynecologic Oncology Surgery
RECRUITING · Phase 4
-
Evaluation of the Effects of Ketorolac Dose on Duration of Analgesia in Emergency Department (ED) Renal Colic Patients
RECRUITING · Phase 4
-
Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia
RECRUITING · Phase 4
-
TAP-patients With Robotic Assisted Lap Prostatectomy
COMPLETED · Phase 4
-
Pecto-intercostal Fascial Block (PIFB) for Postop Analgesia Following Sternotomy in Cardiac Surgery Patients
COMPLETED · Phase 4
-
Benzocaine Versus Placebo Spray for Pain Relief at Hysterosalpingogram
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.